Evidence map›Paper›PMID 22913306›Full record

ArticleThe Journal of oral implantology2012

Si and Ca individually and combinatorially target enhanced MC3T3-E1 subclone 4 early osteogenic marker expression.

Venu G Varanasi, Kelly K Leong, Lisa M Dominia, Stephanie M Jue, Peter M Loomer, Grayson W Marshall

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of oral implantology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular medicine · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Venu G VaranasiDepartment of Biomedical Sciences, Texas A&M Health Science Center, Baylor College of Dentistry, Dallas, TX, USA. venu.varanasi@ucsf.edu
Kelly K Leong
Lisa M Dominia
Stephanie M Jue
Peter M Loomer
Grayson W Marshall
University of California, San Francisco · USTexas A&M University System · US

Funding

Baylor's Program for Bioengineering Sciences and Translational Research "B-BEST"P30DE020742 · NIDCR · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DECHOW, PAUL C · 2009 to 2010
$1.4M
Improving Biomaterials from a Cellular Point of ViewK25DE018230 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VARANASI, VENU GOPAL · 2007 to 2011
$575k
MEMBRANE STUDIES ON SCHISTOSOMA MANSONIF32AI007380 · NIAID · TUFTS MEDICAL CENTER · PI ROSENBERG, IAN M · 1986 to 1988
–
NIAID NIH HHS AI07380NIDCR NIH HHS 1K25 DE018230-01NIDCR NIH HHS 5P30DE020742-02NIDCR NIH HHS K25 DE018230NIDCR NIH HHS P30 DE020742
6 · The paper itself

Abstract

This study tests the hypothesis that silicon and calcium ions combinatorially target gene expression during osteoblast differentiation. MC3T3-E1 subclone 4 osteoblast progenitors (transformed mouse calvarial osteoblasts) were exposed to Si(4+) (from Na(2)SiO(3)) and Ca(2+) (from CaCl(2):H(2)O) ion treatments both individually (0.4 mM each + control treatment) and combinatorially (0.4 mM Si(4+) + 0.4 mM Ca(2+) + control treatment) and compared to control treated (α-minimum essential medium, 10% fetal bovine serum, and 1% penicillin-streptomycin) cells. Cell proliferation studies showed no significant increase in cell density between treatments over 5 days of culture. Cellular differentiation studies involved addition of ascorbic acid (50 mg/L) for all treatments. Relative gene expression was determined for collagen type 1 (Col(I)α1/Col(I)α2), core-binding factor a (cbfa1/Runx2), and osteocalcin (OCN), which indicated osteoblast progenitor differentiation into a mineralizing phenotype. Increased Si(4+) or Ca(2+) ion treatments enhanced Col(I)α1, Col(I)α2, Runx2, and OCN expression, while increased Si(4+) + Ca(2+) ion treatments enhanced OCN expression. Moreover, it was found that a Si(4+)/Ca(2+) ratio of unity was optimal for maximal expression of OCN. Collagen fiber bundles were dense, elongated, and thick within extracellular matrices (ECM) exposed to Si(4+) and Si(4+) + Ca(2+) treatments, while collagen fiber bundles were sparse, short, and thin within Ca(2+) and control treated ECM. These results indicated that individual ions enhance multiple osteogenic gene expression, while combined ion treatments enhance individual gene expression. In addition, these results indicated that Si(4+) enhanced osteoblast gene expression and ECM formation at higher levels than Ca(2+). These results support the larger concept that ions (possibly released from bioactive glasses) could control bone formation by targeting osteoblast marker expression.

Indexed as

3T3 CellsAnimalsAntioxidantsAscorbic AcidCalciumCell CountCell Culture TechniquesCell DifferentiationCell ProliferationCollagen Type ICollagen Type I, alpha 1 ChainCore Binding Factor Alpha 1 SubunitDrug CombinationsExtracellular MatrixGene Expression RegulationMiceAntioxidantsAscorbic AcidCalciumCollagen Type ICollagen Type I, alpha 1 ChainCore Binding Factor Alpha 1 SubunitDrug CombinationsOsteocalcinRunx2 protein, mouseSilicon

Identifiers

PMID22913306
PMCPMC6597170
OpenAlexW2035004116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.